Pallavi Upadhyay, PhD, CMPP

Pallavi Upadhyay, PhD, CMPP, is a scientific writer and laboratory consultant with over 15 years of experience in molecular diagnostics and scientific communications. She has overseen multi-institutional clinical studies and surveillance initiatives, translating complex scientific and real-world data into accessible, evidence-based narratives for clinicians, public health partners, and industry stakeholders. Upadhyay holds a PhD in molecular biology from Texas Woman’s University and has authored multiple peer-reviewed publications in the field of infectious diseases and molecular diagnostics. Her expertise spans molecular assay development, product commercialization, as well as the creation and direction of high-quality, multi-channel scientific content across infectious diseases, molecular testing, and health economics and outcomes research (HEOR) studies.

Home
Author
Pallavi Upadhyay, PhD, CMPP

Articles by Pallavi Upadhyay, PhD, CMPP

This year’s norovirus increase is smaller, but experts warn labs must prioritize early detection, surveillance, and infection control.

Responding to Norovirus: How Laboratories Can Improve Diagnostics and Readiness

Pallavi Upadhyay, PhD, CMPP

Practical strategies to enhance detection, operations, and collaboration to respond effectively to seasonal outbreaks

Illustration of the measles virus particles with the word 'measles' in bold against an orange background.

Why Measles Is Spreading Again—And What It Means for Global Health

Pallavi Upadhyay, PhD, CMPP

Measles is resurging in 2025 as falling vaccination rates and misinformation fuel a growing global health threat

Illustration of a person with a bowed head wearing an N95-type respiratory mask with virus particles, representing norovirus, flu, RSV, and SARS-CoV-2, orbiting around their head against a yellow background.

Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge

Pallavi Upadhyay, PhD, CMPP

The CDC is also tracking a fourth virus called norovirus after unprecedented outbreaks in 14 states, leading to a "quad demic" this season

Illustration of RSV particle.

Everything You Need to Know about RSV

Pallavi Upadhyay, PhD, CMPP

Updates on respiratory syncytial virus (RSV), including diagnostic tools and treatment options

Illustration of a network of monkeypox coinfections on a black computer screen.

Testing for Monkeypox Virus Coinfections

Pallavi Upadhyay, PhD, CMPP

Everything you need to know about monkeypox and its potential coinfections

Photograph of a HIV blood test sample tube.

Four Decades of HIV Testing: Where Do We Stand?

Pallavi Upadhyay, PhD, CMPP

Rapid point-of-care tests and self-tests are critical tools toward eradicating HIV

Colored visualization of monkeypox virus electron microscopy photo.

Monkeypox: What Do We Know So Far?

Pallavi Upadhyay, PhD, CMPP

Update on current monkeypox transmission, detection, prevention, and treatment

Illustration of a clinical lab professional in a lab developing a Lab Developed Test.

Current Challenges Facing Lab Developed Tests

Pallavi Upadhyay, PhD, CMPP

Though challenging, creating lab developed tests is crucial for molecular diagnostics labs

Illustration of the frequency of COVID-19 variants over time

How SARS-CoV-2 Variants Impact COVID-19 Testing

Pallavi Upadhyay, PhD, CMPP

Detecting novel variants can help revise and modify diagnostic tests crucial for effective patient care

COVID-19 patients with coinfections have higher mortality rates than those with single infections

The Danger of COVID-19 Coinfections

Pallavi Upadhyay, PhD, CMPP

COVID-19 patients with coinfections have higher mortality rates than those with single infections

Photo of an array of novel psychoactive substances in pill form on a black background

Novel Psychoactive Substances: Testing Challenges and Strategies

Pallavi Upadhyay, PhD, CMPP

To keep up with emerging NPS, toxicology labs must develop robust assays and update existing testing panels and menus

Photo of a National Health System mobile vaccination clinic bus

Mobile Drug Testing: Driving the Future of Compliance Drug Monitoring

Pallavi Upadhyay, PhD, CMPP

Mobile testing frameworks could help deliver better health care to underserved communities